Hims & Hers Revenue Climbs 49% as Gross Margin Falls to 57%

Hims & Hers Health generated $890.4 million in revenue for the quarter ended Sept. 30, up 49% from $599 million a year earlier. Gross margin fell to 57% from 74% in the third quarter of 2025.

The company posted a $33 million net loss, compared with $15.8 million in net income a year earlier. Adjusted EBITDA was $82.4 million, up from $78.4 million in the same period last year.

Chief Financial Officer Yemi Okupe said, “Revenue grew 49% year-over-year, our second consecutive quarter of acceleration.”

For the fourth quarter of 2026, Hims & Hers forecast revenue of $875 million to $895 million and adjusted EBITDA of $70 million to $90 million. Its full-year revenue guidance is $3.13 billion to $3.15 billion. The company lowered its full-year adjusted EBITDA outlook to $257 million to $277 million.